These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9087534)

  • 41. Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
    Pellicciari C; Mangiarotti R; Bottone MG; Danova M; Wang E
    Cytometry; 1995 Dec; 21(4):329-37. PubMed ID: 8608730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immediate bromodeoxyuridine labelling of unseparated human bone marrow cells ex vivo is superior to labelling after routine laboratory processing.
    Jensen PO; Mortensen BT; Christensen IJ; Larsen JK
    Cell Prolif; 1998 Feb; 31(1):1-7. PubMed ID: 9666814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain.
    Ormerod MG; Kubbies M
    Cytometry; 1992; 13(7):678-85. PubMed ID: 1280554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcome and bromodeoxyuridine-derived proliferation indices in 75 invasive breast carcinomas.
    Cutress RI; Mullee MA; Royle GT; Rew DA
    Eur J Surg Oncol; 2000 Dec; 26(8):747-50. PubMed ID: 11087639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transplantation of human renal cell carcinoma into NMRI nu/nu mice. III. Effect of irradiation on tumor acceptance and tumor growth.
    Otto U; Huland H; Baisch H; Klöppel G
    J Urol; 1985 Jul; 134(1):170-4. PubMed ID: 4009817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of the proliferation in human gastric mucosa after in vivo bromodeoxyuridine labelling.
    Patel S; Rew DA; Taylor I; Potten CS; Owen C; Roberts SA
    Gut; 1993 Jul; 34(7):893-6. PubMed ID: 8344575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of four methods of DNA distribution data analysis based on bromodeoxyuridine/DNA bivariate data.
    Lacombe F; Belloc F; Bernard P; Boisseau MR
    Cytometry; 1988 May; 9(3):245-53. PubMed ID: 3378459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts.
    Bussink J; Kaanders JH; Rijken PF; Martindale CA; van der Kogel AJ
    Br J Cancer; 1998; 77(1):57-64. PubMed ID: 9459146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flow cytometric analysis of DNA ploidy and proliferative potential in brain tumours.
    Gasińska A; Krzyszkowski T; Skołyszewski J; Biesaga B; Gliński B; Pyrich M
    Folia Histochem Cytobiol; 1998; 36(3):133-8. PubMed ID: 9773297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods for cell proliferation analysis by fluorescent image cytometry.
    Souchier C; Ffrench M; Benchaib M; Catallo R; Bryon PA
    Cytometry; 1995 Jul; 20(3):203-9. PubMed ID: 7587705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of an ELISA procedure for the quantitation of bromodeoxyuridine incorporated into cellular DNA.
    Cheitlin RA; Bodell WJ
    Anticancer Res; 1988; 8(3):471-4. PubMed ID: 3389750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lewis lung carcinoma and two transplantable sarcomas in mice as experimental therapy models: biological characteristics and cell population kinetics.
    Gasińska A; Niezabitowski A; Uniwersałl B; Wasilewska A; Lackowska B
    Folia Histochem Cytobiol; 1997; 35(3):165-73. PubMed ID: 9276345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal conditions for immunohistochemical determination of the in vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer.
    Browman GP; Kanclerz A; Booker L; Daya D; Archibald SD; Young JE; Goldsmith CH
    Cell Prolif; 1991 Nov; 24(6):579-85. PubMed ID: 1764538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics.
    Johansson MC; Baldetorp B; Bendahl PO; Fadeel IA; Oredsson SM
    Cell Prolif; 1996 Oct; 29(10):525-38. PubMed ID: 9051116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term serial transplantation of 30 different human renal cell carcinomas into NMRI (nu/nu) mice: flow cytometric, histologic, and growth studies.
    Baisch H; Otto U; Klöppel G
    J Natl Cancer Inst; 1986 Feb; 76(2):269-76. PubMed ID: 2418248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytokinetic properties of asynchronous and cytosine arabinoside perturbed murine tumors measured by simultaneous bromodeoxyuridine/DNA analyses.
    Pallavicini MG; Summers LJ; Dolbeare FD; Gray JW
    Cytometry; 1985 Nov; 6(6):602-10. PubMed ID: 4064840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals.
    Ritter MA; Fowler JF; Kim Y; Lindstrom MJ; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1992; 23(4):811-20. PubMed ID: 1618673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.
    Webster L; Hodgkiss RJ; Wilson GD
    Br J Cancer; 1998; 77(2):227-34. PubMed ID: 9460993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry.
    Shimomatsuya T; Tanigawa N; Muraoka R
    Jpn J Cancer Res; 1991 Mar; 82(3):357-62. PubMed ID: 1902453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NO38 expression and nucleolar counts are correlated with cellular DNA content but not with proliferation parameters in colorectal carcinomas.
    De Angelis PM; Stokke T; Clausen OP
    Mol Pathol; 1997 Aug; 50(4):201-8. PubMed ID: 9350304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.